ERBB2 and breast carcinoma: In breast cancer, high SPHK1 expression was also associated with human epidermal growth factor receptor 2 (HER2) status but not with tumor histological subtypes, histological grade, tumor size or hormone receptor status (Zhu et al. 2017).